Organic Chemistry TRIZ Cases

A biphasic H2O2 oxidation with tungsten oxide catalyst improves fluensulfone yield, limits by-products, and enables catalyst reuse.

Selective pyridinyl triazine derivatives balance broad FGFR-family inhibition with kinase selectivity for cancer treatment.

By merging isothiocyanate activity with surfactant function, this case improves skin delivery while preserving chemoprotective effects.

An alkaline sodium hypochlorite route replaces chlorine gas to produce benzothiazolylsulfenamides with higher purity and lower safety risk.

A heteroaryl electron transport material helps OLEDs sustain low-voltage conduction while improving luminous efficacy, thermal stability, and lifespan.

An amidate catalyst enables blocked polyisocyanate curing below 100°C, cutting energy use while maintaining curing performance.

Bifunctional compounds link a pan-CDK ligand to an E3 ligase binder to selectively degrade CDK2 and CDK5 while limiting off-target toxicity.

Substituted imidazo[1,2-a]pyrazines improve luciferase assay brightness while reducing toxicity, instability, and autoluminescence.

Aminotriazine dithiol compounds with C6-C10 hydrocarbon groups speed CIIR crosslinking while preserving elasticity and reducing additive elution.

Targeted transaminase mutations improve thermal and solvent stability, substrate recognition, and stereoselective chiral amine production.

A donor-acceptor compound in the photoelectric conversion film boosts red and green light quantum efficiency while keeping fabrication practical.

Compounds that promote mitochondrial respiration and shift the heart from fatty acid to glucose oxidation can improve energy efficiency with fewer adverse effects.

Specific Cbl-b inhibitor scaffolds tune T-cell activation while balancing therapeutic potency with compound selectivity.

Alkyl-substituted anodic electrochromic compounds improve solubility in liquid compositions while preserving color reproducibility and contrast.

Chromane mGluR2 PET ligands improve brain uptake and regional heterogeneity, enabling clearer receptor imaging and disorder monitoring.

Substituted pyrazolo[1,5-a]pyrimidines improve BTK inhibition specificity and potency to modulate B-cell signaling in autoimmune and blood cancers.

A fluorinated ether lubricant balances adsorption and smoothness to stabilize head flying and suppress pickup in magnetic recording media.

A PSMA-targeting imaging compound changes probe structure to cut bladder and kidney retention while preserving fast, high-resolution tumor detection.

Chiral amino acid salt resolution boosts Imeglimin HCl purity and yield while reducing impurities and simplifying scale-up work-up.

A bulk-heterojunction film using a Formula (1) compound cuts electric-field dependence of blue-green response speed in imaging sensors.

A hydrogen halide salt additive suppresses B0 and X2 defects in perovskite thin films, extending cell service life under oxygen, moisture, and light.

A two-step esterification converts residual fatty acid instead of washing or distilling it, limiting yellowing and preserving diester purity.

Small-molecule tricyclic WRN inhibitors target dMMR/MSI-H tumors to induce DNA damage and apoptosis with lower normal-tissue toxicity.

Relocating the heteroaryl fusion to a side benzene ring helps OLED host compounds cut driving voltage while improving efficiency and lifespan.

Novel substituted pyridine and phenyl SLC6A19 inhibitors improve solubility and oral bioavailability for metabolic and kidney disorders.

An enzyme-resistant S-nitrosothiol coating enables stable local nitric oxide delivery on medical devices to reduce thrombosis and inflammation.

A spirofluorene-based hole transport material improves charge balance and thermal stability to lower OLED voltage and sustain luminous efficiency.

Novel bisarylether compounds vary aromatic substituents to inhibit cell growth, induce cell death, and enhance Notch signaling.

Pyroglutamic acid resolution replaces slow, costly chiral chromatography to deliver benzodiazepinone derivatives with >99% purity and improved yield.

Donor-aryl dicyanobenzene compounds improve delayed fluorescence efficiency while limiting exciton accumulation in high-current OLEDs.

Adding selective HDAC6 inhibitors to transfected mammalian cell cultures boosts AAV particle titer without complicating production.

Time-gated lanthanide tracer complexes enable background-free reservoir flow-path mapping with trace detection and low rock retention.

Using a deuterated hole transport auxiliary material, this OLED case improves efficiency, lowers driving voltage, and extends lifetime.

By forming Te-O or Te-S bonds from cyclic (thio) ethers and TeX4, this polymer improves refractive index, resist sensitivity, transparency, and UV absorption.

Small-molecule Nrf2 activators release protective signaling, lower ROS, and help prevent neuronal and ovarian cell damage.

A redox-active pantethine trisulfide converts in vivo to persulfide species, enabling vasodilation and broad tissue-protective effects.

Direct amine reaction with polyhydroxyalkanoate avoids metal catalysts and complex steps to produce N-methyl-2-pyrrolidone in high yield.

Hydrophilic EO/PO modification improves 9-phenylacridine solubility and dispersion, cutting developer sludge in PCB photoresists.

UV-to-visible benzotriazole compounds improve photovoltaic encapsulant stability while boosting cell efficiency and service life.

Using two host materials, including a deuterated host, the emitting layer lowers drive voltage while improving quantum efficiency and lifetime.

Non-peptide compounds with a 2-methylpropanamide phenoxy-piperidine scaffold improve BCL9/β-catenin binding while preserving cell permeability.

Fused ring compounds tune substituents and ring chemistry to improve P2X4 inhibition, selectivity, low toxicity, and metabolic stability.

Dry-powder casein kinase 1 inhibitors target airway fibrosis and help overcome glucocorticoid resistance in respiratory disease.

Novel amino and PEG-lipids improve gene editing cargo encapsulation while increasing delivery safety, specificity, and efficiency.

Novel isoquinolinones modulate POLRMT with higher specificity, helping address mitochondrial transcription dysregulation in cancer and metabolic disorders.

N-phenyl pyrrolopyrimidine derivatives target TNBC and other cancer cell lines while addressing the efficacy-toxicity tradeoff in anticancer therapy.

Heterocyclic CCR4 inhibitors are tuned for strong activity while improving bioavailability, formulation properties, and toxicity in inflammatory disease treatment.

Targeting the KxL motif with A27 helps reduce liver fat and inhibit viral replication in NAFLD, NASH, HBV, VEEV, and SARS-CoV-2.

Crystalline and amorphous forms of Compound I improve CFTR modulation by boosting stability and bioavailability for cystic fibrosis treatment.

Heating halo alkyl ethyl ethers with metal in solvent raises halo vinyl ether yields, enabling fluoropolymers with stronger heat and chemical resistance.

1-Cyano-pyrrolidine compounds inhibit USP30 to rescue mitophagy defects and sensitize cancer cells, addressing toxicity issues in existing treatments.

Unsaturated dicarboxylic acids react with thiols to create polymers that resist flame and moisture better than adipic acid.

Replacing expensive reducing agents and complex equipment with catalytic hydrogenation reduces manufacturing cost while maintaining enantiomeric purity.

A carbazole-naphthalene phosphorescent compound balances charge carriers and blocks excitons in organic light-emitting devices.

A pyrolyzed copper-based metal-organic framework electrocatalyst selectively produces isopropanol from carbon dioxide reduction.

Rigid aromatic groups raise the glass transition temperature of host materials, preventing degradation during high-temperature vacuum deposition processes.

Segmenting strong and weak acid generators suppresses acid diffusion, resolving the trade-off between i-line sensitivity and pattern resolution.

Deuterium substitution in host materials reduces non-radiative decay to extend device lifespan while maintaining high luminous efficiency.

Using homogeneous sulfonic acid catalysts with aprotic polar solvents, this method converts sugars to 5-HMF while minimizing unwanted by-product formation.

Formula I to IV compounds replace N-methylpyrrolidone, reducing health and environmental toxicity while maintaining functional properties.

Switching from oxidation to chlorination with a Brønsted acid catalyst resolves low yield issues, achieving high productivity for herbicide intermediates.

Substituted thallium porphyrin complexes prevent crystal deposition in ion-selective membranes, maintaining electromotive force response over time.

Low hydrogen ionic liquids prevent hazardous gaseous decomposition products and pressure buildup when heated above thermal decomposition points.

Bridged bicyclic amino thiazine dioxide compounds modulate beta-secretase activity to reduce amyloid plaque formation without inhibiting Cathepsin D.

Composite host materials resolve the trade-off between driving voltage and luminous efficiency in OLEDs by optimizing molecular structures.

Organic isothiocyanates stabilize anionic dispersion polymerization, preventing hydrocarbon contamination while producing water-soluble flocculants.

Chromosome 1 genetic markers select patients for CRTH2 antagonist therapy, improving FEV1 scores and treatment efficacy.

Hydrazone amide derivatives block the RANKL signaling pathway to inhibit osteoclast differentiation, reducing atypical fracture risk and side effects.

Composite fused ring structures enhance metabolic stability while maintaining potent IRAK4 inhibition for treating related diseases.

A non-chromate conversion coating system treats aircraft foil mesh with a specific chemical solution to maintain electrical conductivity.

A tetrahydro-naphthol derivative serves as a reference standard for high-pressure liquid chromatography analysis of rotigotine impurities.

Formula I compounds inhibit indoleamine 2,3-dioxygenase to reverse immunosuppression and improve cancer treatment efficacy.

Cyclic guanidine host materials improve OLED efficiency and lifetime by managing energy transfer and reducing operating voltage.

Liquid dilactide storage prevents hydrolysis and ring-opening reactions during transport by maintaining the diester in a liquid phase under nitrogen or argon.

Using toluene as a universal solvent simplifies the multi-step rosuvastatin precursor process and reduces solvent handling costs.

Chiral ruthenium catalyst prevents desfluorositagliptin impurity formation during sitagliptin synthesis, ensuring high enantiomeric excess.

Solid-state isocyanurate derivatives prevent roll slippage and mold staining during fluororubber crosslinking.

Modified compounds maintain potency against resistant HIV integrase variants, addressing genetic variation at residues 124 and 125.

Form N-2 crystalline structure prevents conversion during storage, ensuring consistent bioavailability for effective cancer treatment.

Targeted compounds suppress Rac activity to reduce tumor growth and metastasis in resistant breast cancer cases.

A heterobifunctional compound recruits an E3 ubiquitin ligase to destroy the target protein BRD4.

Thermally-labile small molecule inhibitors inactivate DNA polymerase at low temperatures to prevent non-specific amplification during hot-start PCR setup.

An adamantane derivative inhibits Kir6.2 and Kir6.1 channels to enhance cognitive function.

Pyridine compounds targeting calcium-activated potassium channels treat resistant Dirofilaria immitis infections while minimizing host side effects.

Segmenting the cyclopropanecarbonitrile core enables diverse olfactory profiles while reducing synthesis complexity.

Modular benzomorphan scaffolds optimize enzyme binding affinity and pharmacokinetic profiles to treat metabolic disorders.

Allosteric compounds modulate monoamine transporters via state-specific binding to avoid side effects from normal neurotransmitter reuptake interference.

A resist composition incorporating a perfluoroalkyl salt and sulfonium cation enhances pattern formation precision.

A polar polyamine dendritic dispersant stabilizes pigment dispersion through steric barriers.

Replacing methylammonium with formamidinium stabilizes photovoltaic performance, eliminates hysteresis, and extends light absorption to 850 nm.

A common benzopyran intermediate streamlines isoflavonoid production through targeted chemical transformations.

Metal liganded fullerenes increase photospeed by two to ten times, resolving the trade-off between nanometer-scale resolution and exposure sensitivity.

Isoxazole derivatives act as FXR agonists to treat metabolic disorders by improving therapeutic efficacy and specificity.

Moisture-activated Lewis bases heal perovskite defects, boosting efficiency to 22.3% and maintaining stability over 3500 hours.

Deuterated anthracene host and pyrene dopant layers improve blue pixel efficiency and lifespan while managing production costs.

A crystalline form of 7-(dimethoxy-methyl)camptothecin achieves high purity through controlled methanol crystallization.